Stati Uniti - inglese - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - hydroxyzine pamoate (unii: m20215mufr) (hydroxyzine - unii:30s50ym8og) - hydroxyzine hydrochloride 25 mg - for symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. useful in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses, and in histamine-mediated pruritus. as a sedative when used as premedication and following general anesthesia, hydroxyzine may potentiate meperidine (demerol® ) and barbiturates , so their use in pre-anesthetic adjunctive therapy should be modified on an individual basis. atropine and other belladonna alkaloids are not affected by the drug. hydroxyzine is not known to interfere with the action of digitalis in any way and it may be used concurrently with this agent. the effectiveness of hydroxyzine as an antianxiety agent for long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. the physician should reassess periodically the usefulness of the drug for the individual patient. hydroxyzine, when a

Stati Uniti - inglese - NLM (National Library of Medicine)

allergy laboratories, inc. - cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10) - cynodon dactylon pollen 10000 [bau] in 1 ml -       standardized grass pollen extracts are used for the diagnosis and treatment of allergic disease to grass pollen. the standardized (bioequivalent allergy unit) extract in these vials is designed primarily for the physician equipped to prepare dilutions and mixtures as required. standardized grass pollen extracts l a beled in bau/ml are not interchangeable with grass pollen extracts labeled in au/ml or with non-standardized (weight/volume) grass pollen extracts. patients being switched from other types of extracts to allergy laboratories should have their dose adjusted. diagnosis of allergic disease to these grasses is made through a combined medical history sufficiently complete to identify allergic symptoms to grass pollen and identification of grass allergy by diagnostic skin testing. it is recommended that diagnostic skin testing (scratch or puncture) be performed with 10,000 bau/ml grass pollen extracts before testing with 100,000 bau/ml grass pollen extracts. 10,000 bau/ml and 100,000 bau/ml gras

Stati Uniti - inglese - NLM (National Library of Medicine)

larken laboratories, inc. - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - dexamethasone 1.5 mg - allergic states: control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, and serum sickness. dermatologic diseases: bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, and severe erythema multiforme (stevens-johnson syndrome). endocrine disorders: primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; may be used in conjunction with synthetic mineralocorticoid analogs where applicable; in infancy mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, and nonsuppurative thyroiditis. gastrointestinal diseases: to tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis. hematologic disorders: acquired (autoimmune) hemolytic a

Stati Uniti - inglese - NLM (National Library of Medicine)

alvix laboratories - kamdoy rx skin emulsion is indicated as a prescription topical skin care emulsion to manage and relieve the burning and itching experienced with various types of dermatoses, including atopic and allergic contact dermatitis. kamdoy rx skin emulsion helps maintain a moist wound and skin environment, which is beneficial to the healing process. kamdoy rx skin emulsion is contraindicated in persons with a known hypersensitivity to any of the components of the formulation. shake well before use. apply a small amount of product in sufficient quantity to cover the affected skin area to be protected, and allow to dry. reapply up to 4 times per day (or as needed).

Stati Uniti - inglese - NLM (National Library of Medicine)

caraco pharmaceutical laboratories, ltd. - hydroxyzine hydrochloride (unii: 76755771u3) (hydroxyzine - unii:30s50ym8og) - for symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. useful in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses and in histamine-mediated pruritus. as a sedative when used as a premedication and following general anesthesia, hydroxyzine may potentiate meperidine and barbiturates, so their use in preanesthetic adjunctive therapy should be modified on an individual basis. atropine and other belladonna alkaloids are not affected by the drug. hydroxyzine is not known to interfere with the action of digitalis in any way and it may be used concurrently with this agent. the effectiveness of hydroxyzine as an antianxiety agent for long term use, that is more than 4 months, has not been assessed by systematic clinical studies. the physician should reassess periodically the usefulness of the drug for the individual patient. hydroxyzine, when administered t

Stati Uniti - inglese - NLM (National Library of Medicine)

larken laboratories, inc. - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - allergic states: control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, and serum sickness. dermatologic diseases: bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, and severe erythema multiforme (stevens-johnson syndrome). endocrine disorders: primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; may be used in conjunction with synthetic mineralocorticoid analogs where applicable; in infancy mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, and nonsuppurative thyroiditis. gastrointestinal diseases: to tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis. hematologic disorders: acquired (autoimmune) hemolytic a

Stati Uniti - inglese - NLM (National Library of Medicine)

phytopia co., ltd. - balsam peru oil (unii: dik0395679) (balsam peru oil - unii:dik0395679), cocoa butter (unii: 512oyt1crr) (cocoa butter - unii:512oyt1crr) - use helps to reduce stretch marks. directions apply on skin and gentlely massage around abdomen.

Stati Uniti - inglese - NLM (National Library of Medicine)

alvix laboratories - kamdoy rx skin emulsion is indicated as a prescription topical skin care emulsion to manage and relieve the burning and itching experienced with various types of dermatoses, including atopic and allergic contact dermatitis. kamdoy rx skin emulsion helps maintain a moist wound and skin environment, which is beneficial to the healing process. kamdoy rx skin emulsion is contraindicated in persons with a known hypersensitivity to any of the components of the formulation.

Unione Europea - inglese - EMA (European Medicines Agency)

pfizer europe ma eeig  - crisaborole - dermatitis, atopic - other dermatological preparations - staquis is indicated for treatment of mild to moderate atopic dermatitis in adults and paediatric patients from 2 years of age with ≤ 40% body surface area (bsa) affected.

Unione Europea - inglese - EMA (European Medicines Agency)

pfizer europe ma eeig  - abrocitinib - dermatitis, atopic - other dermatological preparations - cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.